000 | 01918 a2200589 4500 | ||
---|---|---|---|
005 | 20250513062459.0 | ||
264 | 0 | _c19940425 | |
008 | 199404s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNakamura, K | |
245 | 0 | 0 |
_aChimeric anti-ganglioside GM2 antibody with antitumor activity. _h[electronic resource] |
260 |
_bCancer research _cMar 1994 |
||
300 |
_a1511-6 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xgenetics |
650 | 0 | 4 | _aAntibody-Dependent Cell Cytotoxicity |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 |
_aComplement System Proteins _ximmunology |
650 | 0 | 4 | _aCytotoxicity, Immunologic |
650 | 0 | 4 |
_aDNA, Complementary _xgenetics |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aG(M2) Ganglioside _ximmunology |
650 | 0 | 4 |
_aGene Expression _xgenetics |
650 | 0 | 4 |
_aGenetic Vectors _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin Heavy Chains _xgenetics |
650 | 0 | 4 |
_aImmunoglobulin Light Chains _xgenetics |
650 | 0 | 4 |
_aImmunoglobulin M _xgenetics |
650 | 0 | 4 |
_aImmunoglobulin Variable Region _xgenetics |
650 | 0 | 4 |
_aImmunoglobulin gamma-Chains _xgenetics |
650 | 0 | 4 |
_aImmunoglobulin kappa-Chains _xgenetics |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 | _aTransplantation, Heterologous |
700 | 1 | _aKoike, M | |
700 | 1 | _aShitara, K | |
700 | 1 | _aKuwana, Y | |
700 | 1 | _aKiuragi, K | |
700 | 1 | _aIgarashi, S | |
700 | 1 | _aHasegawa, M | |
700 | 1 | _aHanai, N | |
773 | 0 |
_tCancer research _gvol. 54 _gno. 6 _gp. 1511-6 |
|
999 |
_c8136579 _d8136579 |